Mark Willenbring

Mark Willenbring.jpg

Mark Willenbring, MD, is founder and CEO of Alltyr, Inc., a company dedicated since 2010 to establishing treatment for addiction based on science rather than ideology. He previously directed the Division of Treatment and Recovery Research at the National Institutes of Alcohol Abuse and Alcoholism (NIAAA). Dr. Willenbring blogs at Substance Matters, and he can be reached at [email protected]. You can find Dr. Willenbring on Linkedin and Twitter.